Dk. Leong et Rf. Butterworth, NEURONAL CELL-DEATH IN WERNICKES ENCEPHALOPATHY - PATHOPHYSIOLOGIC MECHANISMS AND IMPLICATIONS FOR PET IMAGING, Metabolic brain disease, 11(1), 1996, pp. 71-79
Thiamine deficiency in humans is associated with Wernicke's encephalop
athy (WE) which is characterized neuropathologically by neuronal loss
in selective brain regions, Pyrithiamine-induced thiamine-deficiency i
n the rat results in lesions which are similar in nature and distribut
ion to those seen in human WE. Several mechanisms have been implicated
in the pathogenesis of neuronal loss in thiamine deficiency including
, (i) impaired cerebral energy metabolism, (ii) focal lactic acidosis,
(iii) NMDA-receptor mediated excitotoxicity and (iv) blood-brain barr
ier breakdown. WE is difficult to diagnose during life and a large num
ber of cases are missed by routine clinical neurological evaluation. R
ecently, non-invasive diagnostic procedures such as CT and MRI have be
en used for the evaluation of acute and chronic WE. Autoradiographic s
tudies reveal that increased densities of binding sites for the astroc
ytic ligand H-3-PK11195 closely parallel the topographic distribution
of reactive gliosis and neuronal loss in selective brain regions of py
rithiamine-induced thiamine-deficient rats. In contrast, binding sites
for the neuronal ligand H-3-Ro15-1788 show poor regional correlation
with neuronal loss in thiamine deficiency. Both of these ligands are a
vailable, and have been used in PET assessment of various disorders in
humans. The results of autoradiographic studies suggest that C-11-PK1
1195 may offer a useful PET ligand for the assessment of brain damage
in WE in humans.